Non-Disclosure, Evaluation and Option Agreement, dated May 30, 2019, between Shuttle Pharmaceuticals, Inc. and University of Virginia Licensing & Ventures Group

EX-10.23 31 ex10-23.htm

 

Exhibit 10.23